$TDOC

Nueno Carlos sold $47K of TDOC

Nueno Carlos (President, International) sold 6,196 shares of Teladoc Health, Inc. (TDOC) at $7.63 on 2026-06-02.

Original reporting
SEC EDGAR · Nueno Carlos
Published Jun 3, 2026, 8:25 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 3, 2026, 8:36 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$TDOC
Neutral
medium confidence
Mentioned
$TDOC
Relevance
7/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$TDOCNeutralLow
01

Why it matters

The key tradable element is the disclosed insider sale details (date, shares, price, and post-transaction holdings), which can influence short-term sentiment.

02

Market read

A single officer’s small open-market sale is primarily a sentiment/flow datapoint rather than a fundamental driver.

03

What to watch

The sale is not under a 10b5-1 plan, but the disclosed size ($47K) is small relative to typical market capitalization, limiting interpretability.

Relevance 7/10Novelty 6/10Timing: Filed June 3, covering a sale executed June 2.

Background

SEC Form 4 reports insider transactions (officers/directors/10% owners) in the issuer’s own stock.

Company-level read

Ticker impact

$TDOCNeutralMedium confidence
Context

Teladoc Health officer Nueno Carlos sold 6,196 shares in an open-market transaction worth about $47.3K, per SEC Form 4.

Expected impact

Low likelihood of a sustained price move; any reaction is likely limited to short-term sentiment/flow optics.

Evidence & confidence

The filing is a small, non-plan (no 10b5-1) open-market sale by an officer, with no accompanying company-specific news.

Market effects

Minimal; insider selling in one healthcare/telehealth name is not a sector-wide signal on its own.

None indicated.

None indicated.

Counterpoint

Insider sales can be routine liquidity/portfolio rebalancing and may not reflect negative expectations.

Key entities

  • Nueno Carlos

    President, International at Teladoc Health; reported an open-market sale of TDOC shares.

  • Teladoc Health, Inc.

    TDOC; insider selling disclosure filed via SEC EDGAR Form 4.

Related articles

$TDOCMedAI 8/10

Teladoc Health (TDOC) Q2 2026 Earnings Call Transcript

Teladoc Health (TDOC) reported Q2 2026 revenue of $606.9 million, down 4% year over year, with BetterHelp revenue $212.6 million, down 11% due to a faster shift from cash pay to insurance. Adjusted EBITDA was $65.7 million. Full-year 2026 guidance: revenue $2.36B to $2.45B and adjusted EBITDA $271M to $303M. CEO Charles Divita said insurance demand outpaced provider capacity.

$TDOCMedAI 8/10

Teladoc Health (TDOC) Securities Investigation Notice - Levi & Korsinsky

Levi & Korsinsky said it is investigating Teladoc Health (NYSE: TDOC) after the company reported Q2 2026 revenue of $606.9 million, below consensus of $615 million to $628 million, and cut full-year 2026 revenue guidance to $2.36 billion to $2.45 billion. The notice cites prior guidance changes and comments about BetterHelp cash pay user declines and insurance capacity.

$METAMed

Futures Rise As Oil Drops, Bond Selling Slows, Meta Tumbles And Microsoft Soars

US stock index futures rose in premarket after a prior selloff tied to Fed-related concerns. Microsoft shares jumped about 9% after cloud growth accelerated, while Meta fell about 8% after revenue guidance disappointed and free cash flow was weak. Bond selling slowed and 30-year yields hit a two-decade high near 5.22%. Several other earnings moves were reported, including MO, CVNA, CMG, and QCOM.